Published by TMR Research Insights
Posted on September 28, 2021
4 min readLast updated: February 1, 2026
The cardiac rhythm management device market is driven by rising cardiac diseases, with CRT leading. North America dominates, while Asia Pacific grows rapidly.
Implantable Cardiac Rhythm Management Device Market: Introduction
Cardiac rhythm management includes implantable devices which help treat and manage arrhythmia-related diseases such as cardiac arrhythmia, bradycardia, tachycardia, and cardiac synchronization
Implantable cardiac rhythm management devices include pacemaker, implantable cardioverter defibrillator (ICD), and cardiac resynchronization therapy (CRT). Pacemaker is a small device placed in abdomen or chest. It is used in case of slower heart rate than normal. Implantable cardioverter defibrillators (ICDs) used if the heart beats way too faster than normal.
Read Report Overview – https://www.transparencymarketresearch.com/implantable-cardiac-rhythm-management-device-market.html
Key Drivers of Global Implantable Cardiac Rhythm Management Device Market
Increase in number of patients with cardiac diseases is expected to propel the implantable cardiac rhythm management device market. Cardiovascular diseases were a major cause of deaths in 2018, which accounted for 836,546 deaths in the U.S. That is about 1 in 3 deaths in the U.S. In terms of cardiovascular diseases, coronary heart disease is the most leading cause (43.8%) of deaths in the U.S. According to the World Health Organization (WHO), stroke is the third leading cause of disability, worldwide.
Technological advancements, such as leadless pacemaker and MRI-friendliness, are expected to drive the implantable cardiac rhythm management devices market. For instance, in 2017, Abbott received an USFDA approval for Assurity MRI Pacemaker, which eliminates pre- and post-scan pacemaker reprogramming.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75535
Resynchronization Therapy Product Segment to Witness High Demand
Based on product, the global implantable cardiac rhythm management device market can be segmented into pacemaker, implantable cardioverter defibrillator (ICD), and cardiac resynchronization therapy (CRT)
The cardiac resynchronization therapy (CRT) segment accounted for the highest share of the implantable cardiac rhythm management device market in 2018. This segment is expected to dominate the implantable cardiac rhythm management device market during the forecast period, owing to rise in demand for CRT products in developed countries and increased awareness about these products.
Hospitals Segment to Witness Significant Growth
In terms of end-user, the global implantable cardiac rhythm management device market can be divided into hospitals, specialty cardiac centers, and others
The hospitals segment generated the highest revenue in 2018 and is anticipated to witness growth during the forecast period. This can be attributed to strong product penetration and increase in number of surgical procedures. Furthermore, presence of favorable reimbursement facilities is expected to drive the segment during the forecast period.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75535
North America to Dominate Global Implantable Cardiac Rhythm Management Device Market
In terms of region, the global implantable cardiac rhythm management device market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global implantable cardiac rhythm management device market in 2018 and is expected to maintain its leading position during the forecast period. This dominance of the region can be attributed to increase in incidence of cardiovascular diseases, technological advancement, and rise in geriatric population.
The market in Asia Pacific is projected to register highest growth during the forecast period, owing to new product launch from major market players and rise in incidence of cardiac arrhythmia
Pre Book Implantable Cardiac Rhythm Management Device Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=75535<ype=S
Key Manufacturers Operating in Global Market
The global implantable cardiac rhythm management device market was highly fragmented in 2018. Key manufacturers operating in the global market are:
More Trending Reports by Transparency Market Research –
Sinus Dilation Devices Market: https://www.prnewswire.com/news-releases/increasing-research-and-development-to-underscore-growth-in-sinus-dilation-devices-market-forward-from-2018-to-2026-tmr-301109181.html
Sterilization Services Market: https://www.prnewswire.com/news-releases/covid-19-outbreak-will-serve-as-a-growth-booster-for-the-sterilization-services-market-as-frequent-cleaning-and-sanitization-becomes-a-norm-opines-tmr-301284424.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
The article discusses the market trends and forecasts for implantable cardiac rhythm management devices up to 2027.
An increase in cardiac diseases and technological advancements are key drivers of market growth.
North America currently dominates the implantable cardiac rhythm management device market.
Explore more articles in the Research Reports category
